Home › Business & Finance › US Proposes Curbs on Investment in Chinese Biotech Firms
Business & Finance

US Proposes Curbs on Investment in Chinese Biotech Firms

Key Points

US Proposes Curbs on Investment in Chinese Biotech Firms The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines. The US Treasury Department on Thursday proposed adding biotechnology to a list of sensitive technologies subject to restrictions on American investment in foreign adversaries, citing national security concerns.

US Proposes Curbs on Investment in Chinese Biotech Firms The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines. The US Treasury Department on Thursday proposed adding biotechnology to a list of sensitive technologies subject to restrictions on American investment in foreign adversaries, citing national security concerns.
US (LOCATION) Chinese Biotech Firms (ORG) Trump (ORG) American (ORG) Chinese (ORG) China (LOCATION) The US Treasury Department (ORG)
Originally published by Bloomberg Technology Read original →